Success Stories: EB-1B Petition Approved for Senior Research Scientist in Texas in the Field of Cancer Biology

 

Client’s Testimonial:

 

Thank you very much for working on my case and making it a successful submission. My wife and I greatly appreciate your work!”

 


On January 5th, 2016, we received another EB-1B approval for a Senior Research Scientist in the Field of Cancer Biology (Approval Notice).


General Field:  Cancer Biology

Position at the Time of Case Filing: Senior Research Scientist

Country of Origin: India

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Texas

Approval Notice Date: January 5th, 2016

Processing Time: 10 months, 9 days

 

 


Case Summary:

Another of North America Immigration Law Group’s EB-1B (Outstanding Professors and Researchers) clients has received his I-140 approval notice. Just over 10 months after we filed the EB-1B petition on his company’s behalf, we received the good news that our client, a senior research scientist from India, can now take the final step towards his green card.

In this EB1B case, the petitioner was a private biotechnology company. Our attention to detail resulted in a carefully prepared portfolio of evidence that argued that our client’s research is crucial to the field of Cancer Biology. Our team made sure to understand the process and implications of our client’s findings, which located elements that reduced the long-term retention of peptides in the kidneys, and help cancer patients maintain normal bodily functions after therapy.

At the time we filed the petition, our client’s 12 publications had earned his work over 70 citations. He had also reviewed 20 manuscripts on behalf of seven top rated journals. His educational background- a Master’s degree in Chemistry and a Ph.D. in Chemical Sciences- provided a foundation for the remarkable research that qualified him as an Outstanding Professor/Researcher. According to one of his recommenders, “[Client’s] record has demonstrated his distinction among the best professionals in the field, and I am certain that any cessation in his research activity would be at great cost, not only to his fellow scientists but to all who benefit from improved medical technology.”

We are pleased to hear that our hard work has contributed to the success of this client’s case, and we wish him the best in his continued research.